Pharmaceutical compositions comprising calcitonin for intranasal

Details Pharmaceutical compositions comprising calcitonin for intranasal Pharmaceutical compositions comprising calcitonin for intranasal

1994-04-25

1996-05-07

Page, Thurman K.

Drug, bio-affecting and body treating compositions

Effervescent or pressurized fluid containing

Organic pressurized fluid

424 43, 514958, 514970, 514808, A61K 912, A61K 3823

Patent

active

055143652

ABSTRACT:
A method for treating a patient suffering from any of osteoporosis, Paget's disease and hypercalcemia by intranasally administering to said patient by spray a calcitonin solution consisting of calcitonin dissolved in a 0.9% aqueous sodium chloride solution free of quaternary ammonium compounds and surfactants, the calcitonin being in a concentration of 100-5000 IU per ml. of composition.

REFERENCES:
Ganong. (1987). Review of Medical Physiology. Appleton S Lange, pp. 329-331.
Gennaro. (1985). Remington's Pharmaecutical Sciences, Mack Pub., p. 979.

Affiliated with

Also associated with

Rating

Pharmaceutical compositions comprising calcitonin for intranasal does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical compositions comprising calcitonin for intranasal, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compositions comprising calcitonin for intranasal will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1225231